Kevin McCaffrey

Kevin McCaffrey graduated from Rutgers University. He is a reporter with MM&M.

Most Recent Articles by Kevin McCaffrey

Consumers swayed by comparative drug claims: study

Consumers swayed by comparative drug claims: study

In a study to observe their effect in DTC ads, comparison claims in both print and video ads led consumers to trust those drugs over rival medications, researchers found.

Five things for pharma marketers to know:  Thursday, October 23

Five things for pharma marketers to know: Thursday, October 23

FDA panel endorses Novartis psoriasis drug; court rules with Pfizer on cancer drug patent; drugmakers may look for indemnity against losses from Ebola vaccines.

Biogen's strong quarter eclipsed by patient death

Biogen's strong quarter eclipsed by patient death

Despite strong performance by its MS therapies, the drugmaker's robust third-quarter sales were overshadowed by the death of a patient taking Tecfidera.The patient had a rare brain infection.

 Five things for pharma marketers to know: Wednesday, October 22

Five things for pharma marketers to know: Wednesday, October 22

Novo partners with YouTube star for diabetes vids; hedge fund wants Amgen to split up; J&J ramps up Ebola vaccine production.

Five things for pharma marketers to know: Tuesday, October 21

Five things for pharma marketers to know: Tuesday, October 21

Shire bows out of AbbVie acquisition; CVS's PBM will charge premium for consumers who fill scripts at tobacco-selling pharmacies; Reckitt Beckinser will rebrand following demerger.

More Articles by Kevin McCaffrey

Mucinex gets a revamp

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.